Vaxart, Inc. (VXRT) stock
VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48+0.02 (+5.04%)
Close on Oct 19, 2026Market cap $115.61MP/E 4.0Yield –
Vaxart market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vaxart's market cap was $115.47M on Oct 19, 2026, against $76.59M a year earlier. Over the last 5 years it ranged from $76.59M to $997.35M, with a median of $136.99M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $115.47M | +45.6% |
| 2025 | Dec 31, 2025 | $79.31M | -47.3% |
| 2024 | Dec 31, 2024 | $150.61M | +73.8% |
| 2023 | Dec 29, 2023 | $86.66M | -29.7% |
| 2022 | Dec 30, 2022 | $123.20M | -84.3% |
| 2021 | Dec 31, 2021 | $785.60M | +25.7% |
| 2020 | Dec 31, 2020 | $625.07M | +3763.6% |
| 2019 | Dec 31, 2019 | $16.18M | +20.5% |
| 2018 | Dec 31, 2018 | $13.43M | -94.5% |
| 2017 | Dec 29, 2017 | $242.28M | -53.7% |
| 2016 | Dec 30, 2016 | $522.81M | -36.6% |
| 2015 | Dec 31, 2015 | $824.51M | -4.7% |
| 2014 | Dec 31, 2014 | $864.89M | -33.8% |
| 2013 | Dec 31, 2013 | $1.31B | +31.1% |
| 2012 | Dec 31, 2012 | $996.90M | -84.1% |
| 2011 | Dec 30, 2011 | $6.28B | -67.5% |
| 2010 | Dec 31, 2010 | $19.35B | – |
See a number that looks wrong?